Search research articles
Contact Us
Filters
Showing results (341-350 of 489) with videos related to
Page
of 49
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 24, 2017
Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis
Vitaliy Ovod, Kara N Ramsey, Kwasi G Mawuenyega, et al.
Current Alzheimer Research
|
February 6, 2015
Decreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subset
Pratishtha Chatterjee, Veer B Gupta, Anne M Fagan, et al.
JAMA Neurology
|
February 27, 2018
Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease
Sylvia Villeneuve, Jacob W Vogel, Julie Gonneaud, et al.
Neurology
|
March 8, 2019
ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes
Anja Soldan, Corinne Pettigrew, Anne M Fagan, et al.
Brain : a Journal of Neurology
|
October 11, 2018
Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers
Catherine M Roe, Beau M Ances, Denise Head, et al.
Neurology
|
May 1, 2021
Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease
Anna H Boerwinkle, Julie K Wisch, Charles D Chen, et al.
Brain : a Journal of Neurology
|
December 21, 2022
Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression
Julie K Wisch, Omar H Butt, Brian A Gordon, et al.
Annals of Clinical and Translational Neurology
|
October 2, 2022
Comparison of plasma and CSF biomarkers in predicting cognitive decline
Andrew J Aschenbrenner, Yan Li, Rachel L Henson, et al.
The Journal of Clinical Investigation
|
October 22, 2005
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model
John R Cirrito, Rashid Deane, Anne M Fagan, et al.
Plos Genetics
|
August 31, 2013
The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-ε4 carriers
Bruno A Benitez, Celeste M Karch, Yefei Cai, et al.
Page
of 49
Search research articles
Search
Showing results (341-350 of 489) with videos related to
Sort By:
Page
of 49
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 24, 2017
Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis
Vitaliy Ovod, Kara N Ramsey, Kwasi G Mawuenyega, et al.
Current Alzheimer Research
|
February 6, 2015
Decreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subset
Pratishtha Chatterjee, Veer B Gupta, Anne M Fagan, et al.
JAMA Neurology
|
February 27, 2018
Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease
Sylvia Villeneuve, Jacob W Vogel, Julie Gonneaud, et al.
Neurology
|
March 8, 2019
ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes
Anja Soldan, Corinne Pettigrew, Anne M Fagan, et al.
Brain : a Journal of Neurology
|
October 11, 2018
Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers
Catherine M Roe, Beau M Ances, Denise Head, et al.
Neurology
|
May 1, 2021
Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease
Anna H Boerwinkle, Julie K Wisch, Charles D Chen, et al.
Brain : a Journal of Neurology
|
December 21, 2022
Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression
Julie K Wisch, Omar H Butt, Brian A Gordon, et al.
Annals of Clinical and Translational Neurology
|
October 2, 2022
Comparison of plasma and CSF biomarkers in predicting cognitive decline
Andrew J Aschenbrenner, Yan Li, Rachel L Henson, et al.
The Journal of Clinical Investigation
|
October 22, 2005
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model
John R Cirrito, Rashid Deane, Anne M Fagan, et al.
Plos Genetics
|
August 31, 2013
The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-ε4 carriers
Bruno A Benitez, Celeste M Karch, Yefei Cai, et al.
Page
of 49